
    
      Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel designed study
      comparing a dosing regimen of 100 mg approximately 30 minutes prior to breakfast for 12 weeks
      of SUBA™-Itraconazole 50 mg capsules (HalcyGen Ltd) to the approved dosing regimen of 200 mg
      taken with breakfast of SPORANOX® (itraconazole) 100 mg capsules (Janssen Pharma). Patients
      will be randomly assigned in a 3:3:1 ratio to the test product 100 mg once-a-day: reference
      product 200 mg once-a-day: placebo once-a-day. respectively. The patients will complete 5
      visits: baseline/screening (within 28 days of randomization), Day 1 (randomization), Week 6,
      Week 12 and Week 24.
    
  